bax-deficiency promotes drug resistance and oncogenic transformation by attenuating p53-dependent apoptosis

Inactivation of p53-dependent apoptosis promotes oncogenic transformation, tumor development, and resistance to many cytotoxic anticancer agents. p53 can transcriptionally activate bax, a bcl-2 family member that promotes apoptosis. To determine whether bax is required for p53-dependent apoptosis, t...

Full description

Saved in:
Bibliographic Details
Main Authors: McCurrach, Mila E., Connor, Thomas M. F., Knudson, C. Michael, Korsmeyer, Stanley J., Lowe, Scott W.
Format: Artigo
Language:Inglês
Published: The National Academy of Sciences of the USA 1997
Subjects:
Biological Sciences
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC20090/
https://ncbi.nlm.nih.gov/pubmed/9122197
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items